Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Heiner Zimmermann

Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial

scientific article published on 15 April 2013

Early and late posttransplant lymphoproliferative disorder after lung transplantation--34 cases from the European PTLD Network.

scientific article published in August 2013

Effect of dexamethasone on pulmonary and renal angiotensin-converting enzyme concentration in fetal sheep during late gestation

scientific article published on 01 November 2003

End-of-treatment positron emission tomography after uniform first-line therapy of B cell posttransplant lymphoproliferative disorder identifies patients at low risk of relapse in the prospective German PTLD registry.

scientific article published on 17 November 2017

Fcγ-receptor IIIA polymorphism p.158F has no negative predictive impact on rituximab therapy with and without sequential chemotherapy in CD20-positive posttransplant lymphoproliferative disorder.

scientific article published on 10 February 2014

Haemorrhage due to proteolysis of FXIII and hyperfibrinolysis under vemurafenib treatment of metastatic melanoma.

scientific article

IL-6 and IL-10 in post-transplant lymphoproliferative disorders development and maintenance: a longitudinal study of cytokine plasma levels and T-cell subsets in 38 patients undergoing treatment.

scientific article published on 11 June 2011

Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: A retrospective analysis based on the prospective, international, multicenter PTLD-1 trials

scientific article published on 01 November 2018

Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.

scientific article published in March 2012

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

scientific article published on 19 December 2016

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

scientific article published on 13 December 2011

Serum-free light chains adjusted for renal function are a potential biomarker for post-transplant lymphoproliferative disorders

scientific article published on 25 January 2019

Therapeutic options in post-transplant lymphoproliferative disorders

scientific article published on December 1, 2011